Efficacy of teriparatide vs neridronate in adults with osteogenesis imperfecta type I: a prospective randomized international clinical study

Osteogenesis imperfecta (OI) is an hereditary disease characterized by low bone mass, increased bone fragility, short stature, and skeletal deformities, few treatment options are currently available. Neridronate is an amino-bisphosphonate, licensed in Italy for the treatment of OI and Paget’s diseas...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Cases Miner Bone Metab
Huvudupphovsmän: Leali, Paolo Tranquilli, Balsano, Massimo, Maestretti, Gianluca, Brusoni, Matteo, Amorese, Veronica, Ciurlia, Emanuele, Andreozzi, Matteo, Caggiari, Gianfilippo, Doria, Carlo
Materialtyp: Artigo
Språk:Inglês
Publicerad: CIC Edizioni Internazionali 2017
Ämnen:
Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5726200/
https://ncbi.nlm.nih.gov/pubmed/29263724
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11138/ccmbm/2017.14.1.153
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk